h-val-ala-oh

H-Val-Ala-OH (Valyl-alanine) is a dipeptide composed of L-Valine and L-Alanine residues, functioning as a metabolite.

H-Val-Ala-OH-13C5,15N (Valyl-alanine-13C5,15N) TFA is the 13C- and 15N-labeled version of H-Val-Ala-OH. H-Val-Ala-OH (Valyl-alanine) is a dipeptide composed of residues from L-valine and L-alanine. This compound has metabolic functions and exhibits a bitter taste.

CDH17 x GUCY2C BsADC drug linker-1 is a drug-linker conjugate for ADCs. It comprises a GPX4 inhibitor and ferroptosis inducer (RSL3-NH2) paired with a linker (H-Ala-Val-OH). This compound is designed for the synthesis of ADCs.

H-Ile-Lys-Val-Ala-Val-OH (IKVAV) is a short peptide with a sequence length of 5, present in the extracellular matrix (ECM), on the α-laminin chain. H-Ile-Lys-Val-Ala-Val-OH participates in a variety of life activities, such as promoting cell adhesion, neurite outgrowth, angiogenesis, collagenase IV production and tumor growth. H-Ile-Lys-Val-Ala-Val-OH can induce rapid differentiation of neural progenitor cells into neurons and neurite outgrowth.

RYTVELA TFA (H-Arg-Tyr-Thr-Val-Glu-Leu-Ala-OH) is a non-competitive metabotropic interleukin-1 receptor inhibitor with anti-inflammatory activity that inhibits upregulation of inflammation and uterine activation, and may be used for the prevention of preterm labor and for fetal protection.